Autoantibodies to annexins: a diagnostic marker for cutaneous disorders?
暂无分享,去创建一个
E. Bröcker | B. Bastian | J. Römisch | B. Nuss | M. Kraus
[1] E. Bröcker,et al. Localization of annexins in normal and diseased human skin. , 1993, Journal of dermatological science.
[2] E. Bröcker,et al. Inhibition of human skin phospholipase A2 by "lipocortins" is an indirect effect of substrate/lipocortin interaction. , 1993, The Journal of investigative dermatology.
[3] D. Rampton,et al. Antibodies to human recombinant lipocortin-I in inflammatory bowel disease. , 1993, Clinical science.
[4] G. Ciliberto,et al. Anti‐inflammatory actions of an N‐terminal peptide from human lipocortin 1 , 1993, British journal of pharmacology.
[5] L. Berrino,et al. Antiflammins suppress the A23187- and arachidonic acid-dependent chloride secretion in rabbit distal colonic mucosa. , 1992, The Journal of pharmacology and experimental therapeutics.
[6] J. J. Moreno,et al. Antiflammins. Anti-inflammatory activity and effect on human phospholipase A2. , 1992, Biochemical pharmacology.
[7] R. Huber,et al. Crystal and molecular structure of human annexin V after refinement. Implications for structure, membrane binding and ion channel formation of the annexin family of proteins. , 1992, Journal of molecular biology.
[8] J. Römisch,et al. Annexins I to VI: quantitative determination in different human cell types and in plasma after myocardial infarction , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[9] J. Römisch,et al. Detection of human anti-annexin autoantibodies by enzyme immunoassays. , 1992, Journal of immunoassay.
[10] K. Chung,et al. Circulating autoantibodies to recombinant lipocortin-1 in asthma. , 1991, Respiratory medicine.
[11] F. Russo-Marie. Lipocortins: an update. , 1991, Prostaglandins, leukotrienes, and essential fatty acids.
[12] R. Huber,et al. The calcium binding sites in human annexin V by crystal structure analysis at 2.0 A resolution Implications for membrane binding and calcium channel activity , 1990, FEBS letters.
[13] J. McGrath,et al. The presence of autoantibody to recombinant lipocortin‐I in patients with psoriasis and psoriatic arthritis , 1990, The British journal of dermatology.
[14] D. Schlaepfer,et al. Expression of annexins as a function of cellular growth state , 1990, The Journal of cell biology.
[15] R. Flower,et al. Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone , 1990, The Lancet.
[16] J. Pfeilschifter,et al. ‘Antiflammins’: Two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2 ‐inhibitory and anti‐inflammatory activity , 1990, FEBS letters.
[17] T. Lee,et al. Bronchial asthma is not associated with auto‐antibodies to lipocortin‐1 , 1990, Clinical and Experimental Allergy.
[18] J. Ernst,et al. Characterization of Ca2(+)-dependent phospholipid binding, vesicle aggregation and membrane fusion by annexins. , 1990, The Biochemical journal.
[19] J. Römisch,et al. Purification and characterization of six annexins from human placenta. , 1990, Biological chemistry Hoppe-Seyler.
[20] R. Flower,et al. Autoantibodies to recombinant lipocortin-1 in rheumatoid arthritis and systemic lupus erythematosus. , 1989, Annals of the rheumatic diseases.
[21] F. Russo-Marie,et al. A purified lipocortin shares the anti‐inflammatory effect of glucocorticosteroids in vivo in mice , 1989, British journal of pharmacology.
[22] R. Flower,et al. Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[23] J. van Binsbergen,et al. Synthetic peptide from lipocortin I has no phospholipase A2 inhibitory activity , 1989, FEBS letters.
[24] M. Geisow,et al. The annexin family of calcium-binding proteins. Review article. , 1989, Cell calcium.
[25] R. Flower. Lipocortin and the mechanism of action of the glucocorticoids , 1988, British journal of pharmacology.
[26] R. Flower,et al. Recombinant human lipocortin 1 inhibits thromboxane release from guinea-pig isolated perfused lung , 1987, Nature.
[27] H. van den Bosch,et al. Lipocortin inhibition of extracellular and intracellular phospholipases A2 is substrate concentration dependent , 1987, FEBS letters.
[28] H. Hemker,et al. Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. , 1985, European journal of biochemistry.
[29] M. Nirenberg,et al. Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseases. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[30] G. J. Blackwell,et al. Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids , 1980, Nature.
[31] F. Hirata,et al. A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. , 1980, Proceedings of the National Academy of Sciences of the United States of America.